The Blog
-
Sep 11, 2024Targeting Phagocytosis Checkpoints: A New Frontier in Cancer Immunotherapy
READ MORE -
Jun 07, 2024Exploring the Role of Toll-like Receptor (TLR) Agonists in Cancer Therapy
READ MORE -
May 16, 2024Advancements in CD73 Inhibitors: Pioneering Cancer Immunotherapy
READ MORE -
Oct 26, 2023Modulating Treg Homeostasis – Improving Cancer Immunotherapy
READ MORE -
Oct 12, 2023The Efficacy and Safety of Immune Checkpoint Inhibitors in Treating Melanoma
READ MORE -
Jun 02, 2023Tim3 – Immune Checkpoint Rookie
READ MORE -
May 19, 2023Targeting Myeloid-Derived Suppressor Cells (MDSCs) through CXCR1/2 Inhibition: The Potential of SX-682 in Cancer Immunotherapy
READ MORE -
May 12, 2023BET Inhibitors: A Promising Strategy for Cancer Therapy
READ MORE -
May 05, 2023Discovery and Summary of New Targets for Cancer Immunity
READ MORE